About Anushka Mukherjee
Anushka's fascination with the stock market and its intricacies began during her time as an equity research intern after graduating with a bachelor's degree in commerce.
To kickstart her professional journey, she embarked on the role of an Investment Analyst while concurrently pursuing the CFA program.
Anushka's ultimate aim is to equip investors with essential knowledge that empowers them to make well-informed investment choices and attain sustained financial prosperity in the long run.
Recent Articles By Anushka Mukherjee
UPS Earnings Impact: Buy or Sell Signals for Investors
Delivery giant United Parcel Service (UPS) is all set to unveil its fiscal fourth-quarter earnings on January 30. However, with macroeconomic conditions dampening the company’s performance in the third quarter, what stance should investors take with regard to this stock ahead of its earnings release? Read more to find out…
3 Energy Stocks to Buy BEFORE January Ends
The energy sector’s prospects remain solid amid escalating geopolitical tensions, resilient demand, and production cuts. In such a scenario, three fundamentally sound energy companies, Enterprise Products Partners (EPD), Cheniere Energy Partners (CQP), and ChampionX Corp (CHX), could be wise portfolio additions this month. Read on…
Amazon.com (AMZN) vs. Etsy (ETSY) - Which Internet Stock Is Winning Investors Over?
With a surge in online activity and increased demand for internet services, the prospects for the internet industry seem promising. Amid this, which internet retailer, Amazon.com (AMZN) or Etsy, Inc. (ETSY), is better suited for your portfolio amid the industry tailwinds? Keep reading to find out…
3 Biotech Stock Gems Bursting With Buy Opportunities
The biotech industry is well poised to flourish, buoyed by its commitment to innovation and potential for groundbreaking discoveries. Thus, investing in the shares of three fundamentally solid biotech companies, Foghorn Therapeutics (FHTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD), might be prudent. Continue reading…
Apple (AAPL) vs. Dell Technologies (DELL): Buy or Sell Potential
The tech industry appears poised for sustained expansion, attributed to increasing investments in innovation and the continuous trend towards digitalization. In light of this, which tech giant, Apple Inc. (AAPL) or Dell Technologies (DELL) could be a superior buy? Keep reading to find out…
AT&T (T): Pre-Earnings Analysis for Investor Decision-Making
Leading telecom giant AT&T Inc. (T) has been making strategic moves in the dynamic landscape of 5G technology and fiber connectivity. With the company’s fiscal fourth-quarter earnings around the corner, what stance should investors adopt with regard to this stock? Read more to find out…
2024 Gain Potential of 3 Home Improvement Stocks Analyzed
The future of the home improvement industry appears bright, driven by technological advancements and a growing enthusiasm among homeowners for renovation projects. In light of this, let’s analyze the fundamentals of three home improvement stocks, Hooker Furnishings Corp (HOFT), Snap-on Incorporated (SNA), and Tile Shop Holdings (TTSH). Read on…
Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings
Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out…
Analyzing 2024 Gain Potential in 3 Medical Stocks
The medical sector is poised for substantial gains this year, fueled by rising cases of chronic diseases and swift technological progress. In light of this, let’s analyze the fundamentals of three medical stocks: Abbott Laboratories (ABT), Agilent Technologies (A), and Viemed Healthcare (VMD). Read on…